Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,870,729
-
Share change
-
-1,171,964
-
Total reported value
-
$22,160,000
-
Price per share
-
$1.49
-
Number of holders
-
12
-
Value change
-
+$146,069
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM (BLPH) as of Q1 2017
As of 31 Mar 2017,
BELLEROPHON THERAPEUTICS INC - COM (BLPH) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,870,729 shares.
The largest 10 holders included
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C., Boxer Capital, LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, LPL Financial LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, and Creative Planning.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.